2025 revenue consensus $5.25B.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ONC:
- BeOne Medicines’ New Study on BG-75202: A Potential Game-Changer in Cancer Treatment?
- BeOne Medicines Advances in Oncology with Promising BG-T187 Study
- BeOne Medicines Advances in Multiple Myeloma Treatment with Sonrotoclax Study
- BeOne Medicines Advances CLL Treatment with Promising Phase 3 Study
- BeOne Medicines Advances CLL and SLL Treatment with Promising Phase 3 Study